Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV
AM Lambeir, C Durinx, S Scharpé… - Critical reviews in …, 2003 - Taylor & Francis
Dipeptidyl-peptidase IV/CD26 (DPP IV) is a cell-surface protease belonging to the
prolyloligopeptidase family. It selectively removes the N-terminal dipeptide from peptides …
prolyloligopeptidase family. It selectively removes the N-terminal dipeptide from peptides …
The multifunctional or moonlighting protein CD26/DPPIV
E Boonacker, CJF Van Noorden - European journal of cell biology, 2003 - Elsevier
CD26/DPPIV can be considered a moonlighting protein because it is a multifunctional
protein that exerts its different functions depending on cell type and intra-or extracellular …
protein that exerts its different functions depending on cell type and intra-or extracellular …
[HTML][HTML] Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog
HB Rasmussen, S Branner, FC Wiberg… - Nature structural …, 2003 - nature.com
Abstract Dipeptidyl peptidase IV (DPP-IV/CD26) is a multifunctional type II transmembrane
serine peptidase. This enzyme contributes to the regulation of various physiological …
serine peptidase. This enzyme contributes to the regulation of various physiological …
CD26, let it cut or cut it down
I De Meester, S Korom, J Van Damme, S Scharpé - Immunology today, 1999 - cell.com
The costimulatory properties of CD26 have been studied extensively and significant
progress has been made in unravelling the complex nature of this molecule. Here, we …
progress has been made in unravelling the complex nature of this molecule. Here, we …
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
MD Gorrell - Clinical Science, 2005 - portlandpress.com
DP (dipeptidyl peptidase) IV is the archetypal member of its six-member gene family. Four
members of this family, DPIV, FAP (fibroblast activation protein), DP8 and DP9, have a rare …
members of this family, DPIV, FAP (fibroblast activation protein), DP8 and DP9, have a rare …
Dipeptidyl peptidase IV inhibitors for the treatment of diabetes
AE Weber - Journal of medicinal chemistry, 2004 - ACS Publications
Ingestion of food results in the release of peptide hormones in the gut, termed incretins, that
regulate insulin in a glucose-dependent manner. 1 When blood glucose levels are high, the …
regulate insulin in a glucose-dependent manner. 1 When blood glucose levels are high, the …
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function
K Ohnuma, NH Dang, C Morimoto - Trends in immunology, 2008 - cell.com
The role of CD26 in human T cell biology is puzzling. Despite being extensively
characterized, it has been called 'a moonlighting protein'since it has multifunctional effects …
characterized, it has been called 'a moonlighting protein'since it has multifunctional effects …
Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8
CA Abbott, DMT Yu, E Woollatt… - European journal of …, 2000 - Wiley Online Library
Dipeptidyl peptidase (DPP) IV has roles in T‐cell costimulation, chemokine biology, type‐II
diabetes and tumor biology. Fibroblast activation protein (FAP) has been implicated in tumor …
diabetes and tumor biology. Fibroblast activation protein (FAP) has been implicated in tumor …
PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism
S Adams, GT Miller, MI Jesson, T Watanabe, B Jones… - Cancer research, 2004 - AACR
The amino boronic dipeptide, PT-100 (Val-boro-Pro), a dipeptidyl peptidase (DPP) inhibitor,
has been shown to up-regulate gene expression of certain cytokines in hematopoietic tissue …
has been shown to up-regulate gene expression of certain cytokines in hematopoietic tissue …
Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?
CF Deacon, B Ahrén, JJ Holst - Expert opinion on investigational …, 2004 - Taylor & Francis
Inhibitors of the enzyme dipeptidyl peptidase IV (DPP IV) are of increasing interest to both
diabetologists and the pharmaceutical industry alike, as they may become established as …
diabetologists and the pharmaceutical industry alike, as they may become established as …